This is a surprise to me - anyone else?

Discontinued Development – Isradipine

Isradipine was one of two products in an agreement  with Mikah Pharma that was intended to be transferred to Elite for manufacture.

(Phendimetrazine was the second product) Preliminary production batches of Isradipine at Elite, using the equipment provided in the agreement, did not produce acceptable product. Mikah and Elite therefore mutually agreed in an amendment to the agreement to discontinue transfer of the Isradipine.

There's still a lot in the pipeline though - Elite also currently has two products that are pending approval by the FDA for manufacturing transfer and a third undisclosed generic product under FDA review.